ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Recruiting Senior Scientist To Lead AIDS research

May 17, 1996

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

NCCN Updates Breast Cancer Guidelines for Patients

October 31, 2003

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

Feinstein Reintroduces New National Cancer Act

June 13, 2003